April 24, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 20,529 shares of Abrdn Life Sciences Investors at $13.12 per share, a transaction worth $269.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.